Nextech Invest Ltd. current holdings: USA Stocks
Nextech Invest Ltd. reported $0.55 billion in share positions in stocks (listed in the US), 12 positions, in its Form 13F for the quarter ended 2024-12-31; the largest are RVMD, TYRA, ORIC.
- RVMD: Country of operation United States; Class COM; Shares 7,601,087; Value $332,471,545.
- TYRA: Country of operation United States; Class COM; Shares 4,055,861; Value $56,376,468.
- ORIC: Country of operation United States; Class COM; Shares 5,285,714; Value $42,655,712.
- ARVN: Country of operation United States; Class COM; Shares 1,408,394; Value $26,998,913.
Form 13F-HR as filed (SEC CIK 1911010): quarter ended 2024-12-31, filed 2025-02-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
Performance is each holding's price change from its close on the 2024-12-31 quarter end to its latest retained close (2026-09-29, or the date shown for a stock that stopped trading). Price only; dividends are not included. A stock that split in the period is restated by the split ratio in its own Form 8-K; a dash marks a holding with no retained closes.
| Stock | Country of operation | Class | Shares | Value | % of listed | Quarter end | Filed | Performance |
|---|
RVMD
REVOLUTION MEDICINES INC | United States | COM | 7,601,087 | $332,471,545 | 59.26% | 2024-12-31 | 2025-02-14 | +367.49% |
|---|
TYRA
TYRA BIOSCIENCES INC | United States | COM | 4,055,861 | $56,376,468 | 10.05% | 2024-12-31 | 2025-02-14 | +58.13% |
|---|
ORIC
ORIC PHARMACEUTICALS INC | United States | COM | 5,285,714 | $42,655,712 | 7.60% | 2024-12-31 | 2025-02-14 | — split 2026-04-01, ratio not on file |
|---|
ARVN
ARVINAS INC | United States | COM | 1,408,394 | $26,998,913 | 4.81% | 2024-12-31 | 2025-02-14 | — split 2025-03-11, ratio not on file |
|---|
TNGX
TANGO THERAPEUTICS INC | United States | COM | 5,533,980 | $17,099,998 | 3.05% | 2024-12-31 | 2025-02-14 | +690.29% |
|---|
ZYME
ZYMEWORKS INC | United States | COM | 1,113,946 | $16,308,169 | 2.91% | 2024-12-31 | 2025-02-14 | +85.79% |
|---|
RLAY
RELAY THERAPEUTICS INC | United States | COM | 3,846,409 | $15,847,205 | 2.82% | 2024-12-31 | 2025-02-14 | +345.63% |
|---|
CGEM
CULLINAN ONCOLOGY INC | United States | COM | 1,141,145 | $13,899,146 | 2.48% | 2024-12-31 | 2025-02-14 | +25.04% |
|---|
ALMS
ALUMIS INC | United States | COM | 1,476,998 | $11,609,204 | 2.07% | 2024-12-31 | 2025-02-14 | — split 2026-01-06, ratio not on file |
|---|
SPRY
ARS PHARMACEUTICALS INC | United States | COM | 936,729 | $9,882,491 | 1.76% | 2024-12-31 | 2025-02-14 | -58.29% |
|---|
CNTX
CONTEXT THERAPEUTICS INC | United States | COM | 7,419,355 | $7,790,323 | 1.39% | 2024-12-31 | 2025-02-14 | — split 2026-06-15, ratio not on file |
|---|
BOLD
BOUNDLESS BIO INC | United States | COM | 1,228,069 | $3,561,400 | 0.63% | 2024-12-31 | 2025-02-14 | — split 2026-06-23, ratio not on file |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |